Inji ennai for the treatment of kattu mantham( constipation) in children

Clinical evaluation of Inji ennai a Siddha drug in the treatment of Kattumantham in children - constipation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008145

Enrollment

Registered

2017-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- constipation indigestion stomach pain fever cough yawning

Interventions

Intervention1: Ingi Ennai: 5ml - Night only after food Duration 1 day Route of administration -oral route Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: constipation Indigestion stomach pain Fever Cough Yawning

Exclusion criteria

Exclusion criteria: High temperature >102F Intolerable stomach pain

Design outcomes

Primary

Measure	Time frame
clinical efficacy of the trial drug assessed by modified vesikari scoring systemTimepoint: 1 DAY (24 HOURS)	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDrMMeenakshisundaram

National Institute of Siddha

mmssiddha@rediffmail.com9940266442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026